Despite limited evidence, these findings intimate that TXNRD2 and TXNRD3 also inhibit oxidative stress via the thioredoxin system in cancers as TXNRD1, thereby promoting cancer cell resistance to cell death. This evidence concerns the gene TXNRD3 and cancer.